Article
RAS Pathway Mutation Patterns in Patients With Juvenile Myelomonocytic Leukemia: A Developing Country Single-center Experience.
Clinical lymphoma, myeloma & leukemia - 1 Jul 2020
Hamdy Nayera, Bokhary Hossam, Elsayed Amr, Hozayn Walaa, Soliman Sonya, Salem Sherine, Alsheshtawi Khaled, Abdalla Amr, Hafez Hanafy, Hammad Mahmoud
Abstract excerpt
INTRODUCTION: Juvenile myelomonocytic leukemia (JMML) is a rare clonal myelodysplastic/myeloproliferative neoplasm of early childhood. Historically, it was difficult to diagnose clinically, as patients present with manifestations shared with other hematologic malignancies or viral infections. It is now clear that JMML is a disease of hyperactive RAS signaling. PATIENTS AND METHODS: We examined the bone marrow of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
